AAAAAA
Results:
1-13
|
Results: 13
Authors:
Rychlik, I
Petrtyl, J
Tesar, V
Stejskalova, A
Zabka, J
Bruha, R
Citation: I. Rychlik et al., Transjugular renal biopsy - Our experience with 67 cases, KIDNEY BL P, 24(3), 2001, pp. 207-212
Authors:
Broulik, PD
Tesar, V
Zima, T
Jirsa, M
Citation: Pd. Broulik et al., Impact of antihypertensive therapy on the skeleton: Effects of enalapril and AT(1) receptor antagonist losartan in female rats, PHYSL RES, 50(4), 2001, pp. 353-358
Authors:
Zima, T
Tesar, V
Richardson, PJ
Mantle, D
Preedy, VR
Citation: T. Zima et al., Effects of doxorubicin (adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities, TOX APPL PH, 171(3), 2001, pp. 135-140
Authors:
Tesar, V
Citation: V. Tesar, The Czech Society of Nephrology - An introduction, KIDNEY BL P, 23(2), 2000, pp. 73-74
Authors:
Chabova, V
Tesar, V
Zabka, J
Rychlik, I
Merta, M
Jirsa, M
Stejskalova, A
Citation: V. Chabova et al., Long term treatment of IgA nephropathy with cyclosporine A, RENAL FAIL, 22(1), 2000, pp. 55-62
Authors:
Tesar, V
Jelinkova, E
Jirsa, M
Bakosova, M
Pitha, P
Chabova, V
Citation: V. Tesar et al., Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange, BLOOD PURIF, 18(2), 2000, pp. 115-120
Authors:
Rysava, R
Merta, M
Tesar, V
Jirsa, M
Zima, T
Citation: R. Rysava et al., Can serum amyloid a or macrophage colony stimulating factor serve as marker of amyloid formation process?, BIOC MOL B, 47(5), 1999, pp. 845-850
Authors:
Bartunkova, J
Sediva, A
Vencovsky, J
Tesar, V
Citation: J. Bartunkova et al., Primary Sjogren's syndrome in children and adolescents: Proposal for diagnostic criteria, CLIN EXP RH, 17(3), 1999, pp. 381-386
Authors:
Zima, T
Tesar, V
Mestek, O
Nemecek, K
Citation: T. Zima et al., Trace elements in end-stage renal disease - 1. Methodological aspects and the influence of water treatment and dialysis equipment, BLOOD PURIF, 17(4), 1999, pp. 182-186
Authors:
Zima, T
Tesar, V
Mestek, O
Nemecek, K
Citation: T. Zima et al., Trace elements in end-stage renal disease - 2. Clinical implication of trace elements, BLOOD PURIF, 17(4), 1999, pp. 187-198
Authors:
Rychlik, D
Andrassy, K
Waldherr, R
Zuna, I
Tesar, V
Jancova, E
Stejskalova, A
Citation: D. Rychlik et al., Clinical features and natural history of IgA nephropathy (vol 150, pg 117,1999), ANN MED IN, 150(3), 1999, pp. 272-272
Authors:
Rychlik, I
Andrassy, K
Waldherr, R
Zuna, I
Tesar, V
Jancova, E
Stejskalova, A
Ritz, E
Citation: I. Rychlik et al., Clinical features and natural history of IgA nephropathy, ANN MED IN, 150(2), 1999, pp. 117-126
Authors:
Zima, T
Mestek, O
Nemecek, K
Bartova, V
Fialova, J
Tesar, V
Suchanek, M
Citation: T. Zima et al., Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients, BLOOD PURIF, 16(5), 1998, pp. 253-260
Risultati:
1-13
|